OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Adverse tumor events induced by ranitidine: an analysis based on the FAERS database
ManTing Liu, DongQiang Luo, JiaZhen Jiang, et al.
Expert Opinion on Drug Safety (2024), pp. 1-13
Closed Access | Times Cited: 4
ManTing Liu, DongQiang Luo, JiaZhen Jiang, et al.
Expert Opinion on Drug Safety (2024), pp. 1-13
Closed Access | Times Cited: 4
Showing 4 citing articles:
Safety issues of donepezil combined with memantine in Alzheimer’s disease population: real-world pharmacovigilance
Yi Zeng, Bingshuo Liu, Lisi Zhou, et al.
Expert Opinion on Drug Safety (2025)
Closed Access | Times Cited: 1
Yi Zeng, Bingshuo Liu, Lisi Zhou, et al.
Expert Opinion on Drug Safety (2025)
Closed Access | Times Cited: 1
A study on the pharmacovigilance of various SGLT-2 inhibitors
Yanwen Dong, Yangyang Wang, Xiao-mei Lan, et al.
Frontiers in Medicine (2025) Vol. 11
Open Access
Yanwen Dong, Yangyang Wang, Xiao-mei Lan, et al.
Frontiers in Medicine (2025) Vol. 11
Open Access
The adverse reactions of bevacizumab in combination with the FOLFOX chemotherapy regimen in metastatic colorectal cancer
DongQiang Luo, Jiyuan Zheng, Bingshuo Liu, et al.
Expert Opinion on Drug Safety (2025)
Closed Access
DongQiang Luo, Jiyuan Zheng, Bingshuo Liu, et al.
Expert Opinion on Drug Safety (2025)
Closed Access
Adverse events associated with carbamazepine: a pharmacovigilance study using the FDA Adverse Event Reporting System
Shulan Huang, Hanlin Dong, Dongqiang Luo, et al.
Expert Opinion on Drug Safety (2024), pp. 1-13
Closed Access | Times Cited: 2
Shulan Huang, Hanlin Dong, Dongqiang Luo, et al.
Expert Opinion on Drug Safety (2024), pp. 1-13
Closed Access | Times Cited: 2
Adverse reaction of specific acute kidney injury caused by atorvastatin: an actual study based on the database of the US FDA adverse event reporting system
Manting Liu, Zhenye Chen, Jiazhen Jiang, et al.
Expert Opinion on Drug Safety (2024)
Closed Access
Manting Liu, Zhenye Chen, Jiazhen Jiang, et al.
Expert Opinion on Drug Safety (2024)
Closed Access
